| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 164.70B | 150.87B | 172.10B | 180.34B | 199.32B | 148.93B |
| Gross Profit | 29.18B | 25.36B | 30.64B | 33.35B | 41.84B | 25.69B |
| EBITDA | 21.38B | 10.97B | 22.80B | 25.61B | 34.28B | 18.09B |
| Net Income | 9.98B | 7.21B | 11.58B | 13.56B | 19.70B | 8.47B |
Balance Sheet | ||||||
| Total Assets | 215.87B | 219.41B | 217.46B | 219.99B | 222.29B | 187.49B |
| Cash, Cash Equivalents and Short-Term Investments | 9.49B | 11.28B | 9.52B | 17.03B | 11.91B | 12.65B |
| Total Debt | 76.32B | 80.53B | 79.44B | 82.02B | 90.08B | 75.84B |
| Total Liabilities | 119.53B | 118.10B | 120.86B | 130.25B | 142.67B | 125.32B |
| Stockholders Equity | 96.16B | 101.11B | 96.41B | 89.49B | 79.61B | 62.16B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.85B | -250.00M | 18.76B | -9.48B | -16.73B |
| Operating Cash Flow | 0.00 | 13.54B | 11.04B | 26.82B | 3.65B | -697.00M |
| Investing Cash Flow | 0.00 | -9.38B | -11.39B | -7.92B | -13.04B | -15.66B |
| Financing Cash Flow | 0.00 | -2.73B | -7.39B | -14.32B | 8.53B | 15.05B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥434.26B | 12.05 | ― | 3.26% | -6.84% | 4.65% | |
71 Outperform | ¥180.09B | 27.66 | 5.06% | 1.80% | 1.69% | 71.95% | |
69 Neutral | ¥739.64B | 7.95 | 10.78% | 4.68% | -4.64% | -21.94% | |
65 Neutral | ¥65.48B | 9.27 | ― | 5.15% | -12.34% | -36.53% | |
62 Neutral | ¥371.52B | 11.21 | 6.16% | 2.99% | 0.55% | 20.51% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | ¥78.83B | 13.13 | ― | 3.70% | -2.40% | -8.59% |